Anti-Inflammatory Drug Can Reduce Parkinson's Disease Symptoms
Faculty member in Immunology and Molecular Pathogenesis, Dr. Malu Tansey, is mentioned in Nature World News for her research on anti-inflammatory therapies for Parkinson's disease.
"This is an important step forward for anti-inflammatory therapies for Parkinson's disease," said Tansy. "Our results provide a compelling rationale for moving toward a clinical trial in early Parkinson's disease patients."
This experimental drug can protect vulnerable neurons and reduce motor deficits in rat models with Parkinson's.